Hepatitis C. New treatment helps some, but cure remains elusive.
Henkel
J
J
D000998:Antiviral Agents / Q000627:therapeutic use*; D004338:Drug Combinations; D006526:Hepatitis C / Q000188:drug therapy / Q000628:therapy* / Q000635:transmission; D006525:Hepatitis, Viral, Human / Q000209:etiology / Q000628:therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use; D012307:Risk Factors; D065227:Transfusion Reaction
D000998:Antiviral Agents; D004338:Drug Combinations; D000077190:Interferon alpha-2; D016898:Interferon-alpha; C118689:Rebetron; D011994:Recombinant Proteins; D012254:Ribavirin; D007372:Interferons